Tag: FDA recalls

Nitrosamine Contamination in Generics: Recent Cases and Regulatory Response

Nitrosamine Contamination in Generics: Recent Cases and Regulatory Response

Nitrosamine contamination in generic drugs has triggered dozens of recalls since 2018. Learn how cancer-causing impurities slipped into medications like valsartan and metformin-and how the FDA is responding.

RECENT POSTS

November 18, 2025
Statins and ALS: What the Latest Research Really Shows

Statins and ALS: No proven link exists. Latest research shows long-term statin use may reduce ALS risk, while early symptoms often cause mistaken fear. Don't stop statins without medical advice.

July 12, 2023
Elevate Your Wellness Game with the Power of Arenaria Rubra Dietary Supplement

I've recently discovered a game-changer for wellness, the Arenaria Rubra dietary supplement. This little-known natural powerhouse is full of benefits that can boost your overall health and vitality. It's amazing how it supports everything from our digestive system to our skin health. I've been incorporating it into my daily routine, and I can genuinely feel the difference. If you're looking to elevate your wellness game, Arenaria Rubra is definitely worth considering.

September 30, 2025
Nasonex Nasal Spray vs. Top Alternatives: A Detailed Comparison

A thorough comparison of Nasonex (mometasone furoate) with Flonase, Rhinocort, Nasacort, and other alternatives, covering potency, cost, age suitability, side‑effects, and best‑fit scenarios.

January 3, 2026
Cost Barriers to Medication Adherence and How to Get Help

Cost is the top reason people skip doses or don't fill prescriptions. Learn how high drug prices hurt health, why it's not your fault, and what real help is available-from patient programs to Medicare changes and free discount tools.

January 24, 2026
UK Substitution Laws: How NHS Policies Are Changing Generic Medicines and Care Delivery

UK substitution laws are reshaping how the NHS delivers medicines and care, pushing generics and remote services to cut costs. But without enough staff and support, these changes risk leaving vulnerable patients behind.